• Legislation dealing with Clinical Laboratory issues. VALID Act, PAMA (SALSA Bill). COVID Relief Bills. Medical procedure and testing code issues. Price transparency legislation.
• Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate.
• COVID testing reimbursement, coverage and reimbursement issues under PAMA (the SALSA Bill). General lab reimbursement issues under Medicare.

Duration: December 1, 2020 to present

General Issues: Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Budget/Appropriations

Spending: about $530,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2020: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS)